MINNEAPOLIS--(BUSINESS WIRE)--Following elections, LifeScience Alley announces the addition of 10 new directors to its board: Sheri Dodd, vice president and general manager, patient management services, Medtronic, LLC; Maura Donovan, executive director, University of Minnesota Office of University Economic Development; Steffen Hovard, senior vice president, urology care, Coloplast; Lee Jones, founder, president and CEO, Rebiotix Inc.; Ann Ladd, shareholder, Fredrikson & Byron, P.A.; Jeff McCaulley, president and CEO, Smiths Medical; Tim Pelura, president and CEO, Surpass, Inc.; Jim Rogers, chair, Mayo Clinic Ventures; Lisa Shafer, vice president, pharmaceutical R&D, Upsher-Smith Laboratories, Inc. and Nicole Walker, principal, Baird Capital.
“We are proud and very excited to work with a board of directors that represents the breadth and depth of industry and business leadership necessary to serve the world’s greatest health technology community,” states Shaye Mandle, president and CEO, LifeScience Alley. “As the healthcare marketplace brings great change to all parties involved, we believe that the organizations and individuals in our community will continue to play a vital role in driving the direction and magnitude of that change.”
The new directors join existing officers and board members, including Board Chair Robert Kieval, executive vice president and chief technology officer of CVRx, Inc.; Vice Chair Rachel Ellingson, vice president of global communications for St. Jude Medical and president of the St. Jude Medical Foundation; Treasurer Kevin Smith, partner at KPMG, LLP; Secretary Steven Mertens, senior vice president of operations for Holaira; Tim Frischmon, principal, Furst Group; Joseph Galatowitsch, president and managing partner of Dymedex Consulting, LLC; Ed Hedblom, director of clinical research for 3M Health Care Business Group; Bill McCormick, executive vice president (retired), The Schwan Food Company and Jeff Mirviss, senior vice president and president of peripheral interventions, Boston Scientific Corporation.
“In its role leading Minnesota’s Medical Alley region, LifeScience Alley is a powerful resource to the global health technology and care community,” says Board Chair Robert Kieval. “I look forward to working with my fellow board members and the organization’s leadership and staff to foster an environment that enables health technology and care organizations to innovate, succeed and influence the evolution of healthcare.”
About LifeScience Alley
LifeScience Alley is a global leader in enabling health technology and care organizations to innovate, succeed and influence the evolution of healthcare. By influencing proactive policy change, delivering actionable information and intelligence and uniting members with critical resources, we work to ensure that Minnesota's Medical Alley remains the world's strongest health technology community. The Association’s membership and supporting community extends throughout the world, employing more than 300,000 Minnesotans and many more globally. Learn more at www.LifeScienceAlley.org.